Legend Biotech (LEGN) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 13, 2026

Net selling: insiders sold $309K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: -$309K net
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Jun 30, 2026: 1 added, 1 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about LEGN filings

Are insiders buying or selling Legend Biotech Corp (LEGN) stock?

Net selling: insiders sold $309K and bought $0 of LEGN stock on the open market in the 90 days to Nov 13, 2026, according to SEC Form 4 filings. The largest was Sanders, Corazon (Corsee) D. (Director), who sold $259K. The latest filing was on Oct 1, 2026.

Which members of Congress have traded LEGN recently?

None. No member of Congress disclosed a LEGN trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this LEGN smart-money data?

This summary uses filings available on Nov 13, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

13F: filed up to 45 days late.

Smart money on LEGN

Lean short1 source:
- Insiders
Neutral1 source:
- Funds

Top traders
No tracked positions at the last update
Insiders
Lean short3 sales · $397K
Form 4 filings, open market.
Congress
No recent politician filings found
Funds
- Two Sigma, trimmed -$29.5M, holdings at Jun 30
- JPMorgan Chase, added +$17.5M, holdings at Jun 30
Neutral · thin1 added · 1 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Influencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about LEGN filings

Are insiders buying or selling Legend Biotech Corp (LEGN) stock?

Which members of Congress have traded LEGN recently?

None. No member of Congress disclosed a LEGN trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this LEGN smart-money data?

Funds

What funds are doing

2 moves · 6 mo

Buys/Adds$17.5MSells/Trims$29.5M

Buys/Adds (1)

JC
JPMorgan Chase
Q2 2026 13F
$17.5M
added
Signals like this: n=13773, 53% finished lower at D15, median -0.4% vs SPY -0.4%

Sells/Trims (1)

TS
Two Sigma
Q2 2026 13F
$29.5M
trimmed
Signals like this: n=7469, 53% finished lower at D15, median -0.5% vs SPY -0.4%

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 10, 2026

Earnings came in $0.27 a share above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 10, 2026

Period ending

Sep 30, 2026

Earnings per share

$0.28+$0.27 beat

$0.01 expected

Revenue

$359.5M

SEC filing

EPS: Yahoo Finance

Next report

What the street expects next

Estimates as of Nov 13, 2026

EPS expected

$0.09

$0.09 to $0.09

Revenue expected

$382.0M

9 analysts

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 10, 2026	$0.28est. $0.01	+$0.27beat	$359.5MSEC filing	+32.0%from $272.4M
Jun 30, 2026Reported Aug 11, 2026	$0.09est. $0.12	-25.00%miss	$387.5MSEC filing	+51.9%from $255.1M
Mar 31, 2026Reported May 12, 2026	-$0.15est. $0.01	-$0.16miss	Not on file	Not on file
Dec 31, 2025Reported Mar 10, 2026	-$0.16est. -$0.19	+15.79%beat	$1.03B · FYSEC filing	No year-ago quarter
Sep 30, 2025Reported Nov 12, 2025	-$0.22est. -$0.18	-18.92%miss	$272.4MSEC filing	+70.0%from $160.2M
Jun 30, 2025Reported Aug 11, 2025	-$0.68est. -$0.23	-$0.45miss	$255.1MSEC filing	+36.8%from $186.5M
Mar 31, 2025Reported May 13, 2025	-$0.54est. -$0.34	-58.82%miss	$195.1MSEC filing	+107.5%from $94.0M
Dec 31, 2024Reported Mar 11, 2025	$0.14est. -$0.38	+137.24%beat	$627.3M · FYSEC filing	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $19.10
High: $19.13
Low: $17.86
Prev close: $19.54
52-wk high: $37.50
52-wk low: $16.24
Mkt cap: $3.79B
ROE: -0.0%
Fwd P/E: 24.0x
Beta: 0.55
P/S: 2.8x
P/B: 3.1x
Profit margin: -0.0%
Op margin: +2.8%

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -0.0%
Forward P/E: 24.04
Market cap: $3.8B

Valuation

P/S2.79
P/B3.11

Quality

Operating margin2.8%
ROE-0.0%
ROA1.4%

Growth

Beta0.55

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

15 / 100

RSI 14

47balanced

20D volatility

87%annualized

52-week range

$18.54

$16.24$37.50

20D support

$17.86recent floor

20D resistance

$24.42recent ceiling

Returns

5D -17.7%20D -6.4%60D -18.0%

Price vs moving averages

SMA20 -10.7%SMA50 -5.7%SMA200 -16.5%

Volume pace

1.13xvs prior 20D

Smart money at a glance

Filings to Nov 13, 2026

Net selling: insiders sold $309K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: -$309K net
CongressSTOCK Act, 180 days: None
Big funds13F, quarter ended Jun 30, 2026: 1 added, 1 cut
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about LEGN filings

Are insiders buying or selling Legend Biotech Corp (LEGN) stock?

Which members of Congress have traded LEGN recently?

None. No member of Congress disclosed a LEGN trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this LEGN smart-money data?

13F: filed up to 45 days late.

Smart money on LEGN

Lean short1 source:
- Insiders
Neutral1 source:
- Funds

Top traders
No tracked positions at the last update
Insiders
Lean short3 sales · $397K
Form 4 filings, open market.
Congress
No recent politician filings found
Funds
- Two Sigma, trimmed -$29.5M, holdings at Jun 30
- JPMorgan Chase, added +$17.5M, holdings at Jun 30
Neutral · thin1 added · 1 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Influencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about LEGN filings

Are insiders buying or selling Legend Biotech Corp (LEGN) stock?

Which members of Congress have traded LEGN recently?

None. No member of Congress disclosed a LEGN trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this LEGN smart-money data?

Funds

What funds are doing

2 moves · 6 mo

Buys/Adds$17.5MSells/Trims$29.5M

Buys/Adds (1)

JC
JPMorgan Chase
Q2 2026 13F
$17.5M
added
Signals like this: n=13773, 53% finished lower at D15, median -0.4% vs SPY -0.4%

Sells/Trims (1)

TS
Two Sigma
Q2 2026 13F
$29.5M
trimmed
Signals like this: n=7469, 53% finished lower at D15, median -0.5% vs SPY -0.4%

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 10, 2026

Earnings came in $0.27 a share above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 10, 2026

Period ending

Sep 30, 2026

Earnings per share

$0.28+$0.27 beat

$0.01 expected

Revenue

$359.5M

SEC filing

EPS: Yahoo Finance

Next report

What the street expects next

Estimates as of Nov 13, 2026

EPS expected

$0.09

$0.09 to $0.09

Revenue expected

$382.0M

9 analysts

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 10, 2026	$0.28est. $0.01	+$0.27beat	$359.5MSEC filing	+32.0%from $272.4M
Jun 30, 2026Reported Aug 11, 2026	$0.09est. $0.12	-25.00%miss	$387.5MSEC filing	+51.9%from $255.1M
Mar 31, 2026Reported May 12, 2026	-$0.15est. $0.01	-$0.16miss	Not on file	Not on file
Dec 31, 2025Reported Mar 10, 2026	-$0.16est. -$0.19	+15.79%beat	$1.03B · FYSEC filing	No year-ago quarter
Sep 30, 2025Reported Nov 12, 2025	-$0.22est. -$0.18	-18.92%miss	$272.4MSEC filing	+70.0%from $160.2M
Jun 30, 2025Reported Aug 11, 2025	-$0.68est. -$0.23	-$0.45miss	$255.1MSEC filing	+36.8%from $186.5M
Mar 31, 2025Reported May 13, 2025	-$0.54est. -$0.34	-58.82%miss	$195.1MSEC filing	+107.5%from $94.0M
Dec 31, 2024Reported Mar 11, 2025	$0.14est. -$0.38	+137.24%beat	$627.3M · FYSEC filing	No year-ago quarter

Open: $19.10
High: $19.13
Low: $17.86
Prev close: $19.54
52-wk high: $37.50
52-wk low: $16.24
Mkt cap: $3.79B
ROE: -0.0%
Fwd P/E: 24.0x
Beta: 0.55
P/S: 2.8x
P/B: 3.1x
Profit margin: -0.0%
Op margin: +2.8%

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -0.0%
Forward P/E: 24.04
Market cap: $3.8B

Valuation

P/S2.79
P/B3.11

Quality

Operating margin2.8%
ROE-0.0%
ROA1.4%

Growth

Beta0.55

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

15 / 100

RSI 14

47balanced

20D volatility

87%annualized

52-week range

$18.54

$16.24$37.50

20D support

$17.86recent floor

20D resistance

$24.42recent ceiling

Returns

5D -17.7%20D -6.4%60D -18.0%

Price vs moving averages

SMA20 -10.7%SMA50 -5.7%SMA200 -16.5%

Volume pace

1.13xvs prior 20D

Legend Biotech Corp

Smart money at a glance

What do analysts expect?

Questions about LEGN filings

Smart money on LEGN

Questions about LEGN filings

What funds are doing

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in $0.27 a share above what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Legend Biotech Corp

Smart money at a glance

What do analysts expect?

Questions about LEGN filings

Smart money on LEGN

Questions about LEGN filings

What funds are doing

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in $0.27 a share above what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Legend Biotech Corp

Overview

Questions about LEGN filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Legend Biotech Corp

Overview

Questions about LEGN filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.